VALIDATE Network
@NetworkValidate
Followers
1K
Following
2K
Media
717
Statuses
7K
International network of researchers aiming to accelerate vaccine development for TB, leishmaniasis, melioidosis &leprosy. Led by @UniofOxford - open to all
Oxford, England
Joined July 2017
Cutaneous leishmaniasis affects hundreds of thousands every year, yet few people have heard of it. Join us on 25 February at the Royal Institution to explore the science behind this neglected disease. Please help spread the word. More info:
validate-network.org
What if a single insect bite could leave a permanent mark — not just on your skin, but on your life? - A free public talk from the VALIDATE Network
0
1
0
Dr María Adelaida Gómez has witnessed the social and psychological effects of leishmaniasis firsthand in rural Colombia. Her talk will explore why the disease persists and how science can change lives. Please share this event. Event info: https://t.co/mZeZQUc7Ox
0
0
1
As Co-Director of VALIDATE, Dr Gómez leads global efforts to accelerate vaccine research for neglected diseases. Hear Adelaida's perspective on Leishmaniasis and the development of vaccines at the Royal Institution. Help spread the word. Details:
validate-network.org
What if a single insect bite could leave a permanent mark — not just on your skin, but on your life? - A free public talk from the VALIDATE Network
0
2
2
Join Colombian biomedical scientist Dr María Adelaida Gómez as she reveals the human and scientific story behind cutaneous leishmaniasis on 25 February at the Royal Institution. Please share this event to help us reach a wider audience. More info:
validate-network.org
What if a single insect bite could leave a permanent mark — not just on your skin, but on your life? - A free public talk from the VALIDATE Network
0
0
0
#Article in @MedComm_MC Inflammasome Activation Differences Underpin Different Mycobacterium tuberculosis Infection Outcomes https://t.co/P0y38l8vJi, studied by @selva_trc and his group from @RutgersMens
#HostPathogenInteractions #ImmuneResponse #infection #tuberculosis
0
1
0
Very happy to share our group’s second publication this month! In this work, we investigate the intrinsic anti-tuberculosis activity of polymeric β-cyclodextrin nanoparticles. Proud of the team’s efforts!
0
2
6
An outer membrane vesicle vaccine prevents lung pathology in a macaque model of ... - Nature - https://t.co/JOcFnG1kjK
#GoogleAlerts
nature.com
Nature Communications - Currently, there is no licensed vaccine for Burkholderia pseudomallei, the causative agent of melioidosis. Here, the authors evaluate the efficacy and safety of an...
0
1
0
Tuberculosis (TB) that doesn’t respond to standard drugs is called drug-resistant TB and emerges when TB medicines are used inappropriately. Although the number of people developing drug-resistant TB has declined since 2015, it remains a global public health crisis affecting 390
5
12
41
#Tuberculosis (TB) is preventable and curable. Yet, it remains one of the world’s deadliest infectious killers, claiming 1.23 million lives in 2024. The WHO Global Tuberculosis Report 2025 talks about the gains made so far and the challenges ahead due to severe funding cuts:
36
129
235
Paper: Diagnostic value of five Mycobacterium tuberculosis dormant highly expressed antigens in latent infections and immunogenicity assessment of a novel subunit vaccine PB2-DIMQ https://t.co/ZzGUAIHKNB
0
0
0
Paper: Targeting HspX of Mycobacterium tuberculosis: Advances in diagnostics,...
0
0
0
Protara’s cell therapy touts BCG-naïve treatment potential in Phase II https://t.co/aPy7av4Snf via @TrialsArena
clinicaltrialsarena.com
If Protara's cell therapy TARA-002 reached the market, it would become the first drug to gain approval in the BCG-naïve setting of NMIBC.
0
0
0
New vaccines could help us consign tuberculosis to history: here’s how we can do it https://t.co/okPFqwSWkL via @gavi
gavi.org
New tuberculosis vaccine candidates are currently going through the final stages of clinical trials. We need to work together to ensure they reach the millions who need them quickly and effectively.
0
2
1
A golden era of tuberculosis vaccines is coming – but is the world ready?%20%40wellcometrust
wellcome.org
A golden era of tuberculosis vaccines is coming. Is the world ready? Alex Pym discusses the urgent need for global preparation to ensure they save lives.
0
2
1
IIT Bhubaneswar, ILS transfer novel TB vaccine technology to TechInvention
medicaldialogues.in
Bhubaneswar: Indian Institute of Technology (IIT) Bhubaneswar and the Institute of Life Sciences (ILS), Bhubaneswar, along with the National Research Development Corporation (NRDC), have signed a...
0
1
0
New TB-targeted vaccine: picking up where the BCG left off
thenakedscientists.com
A shot in the arm for science...
0
0
0
We’re pleased to announce the VALIDATE Network’s first in-person public event! Join us at @Ri_Science on 25 Feb 2026 for Chasing Parasites — a free talk by Dr María Adelaida Gómez on the science and human stories behind cutaneous #Leishmaniasis. https://t.co/mZeZQUc7Ox
validate-network.org
What if a single insect bite could leave a permanent mark — not just on your skin, but on your life? - A free public talk from the VALIDATE Network
0
3
2
Diagnostic potential of GLP recombinant antigens in whole blood assays for Leishmania infantum infection https://t.co/WpeIIa9d0J
link.springer.com
Parasites & Vectors - The whole blood stimulation assay (WBA) is a valuable tool for detecting asymptomatic Leishmania infection and monitoring the treatment of visceral leishmaniasis (VL)....
0
0
0
ILS, IIT-Bhubaneswar collaborate on new tuberculosis vaccine
newindianexpress.com
BHUBANESWAR : In a significant breakthrough, the Institute of Life Sciences (ILS), Bhubaneswar has developed a next-generation subunit vaccine for tuberculosis
0
1
0
Two-day training held in Nicobar on adult BCG vaccination protocols https://t.co/i5tbyrMgPB via @TheWaveAndaman
thewaveandaman.com
Two-day adult BCG vaccination training held in Nicobar District, offering technical guidance to medical officers and health staff.
0
1
0